-
Anthem Will Account For 21%-22% Of Express Scripts' Scripts In 2016, Says Morgan Stanley
Monday, March 14, 2016 - 3:31pm | 436Read More...Health insurer Anthem Inc (NYSE: ANTM) is expected to account for 21-22 percent of the scripts of Express Scripts Holding Company (NASDAQ: ESRX) in 2016, according to a report from Morgan Stanley. Express Scripts shares have dropped 19 percent this year, mainly driven by the contract dispute...
-
Who Will Feel The Pain From Generic Drug Price Inflation?
Saturday, December 13, 2014 - 12:43pm | 368Read More...A recent Morgan Stanley report presented analysts’ case for why they believe that generic drug prices will be on the rise in the near future. Reasons for generic drug price inflation include increased FDA regulatory obstacles, consolidation of generic drug producers, and increasing...
-
Morgan Stanley Previews Walgreens' November Same-Store Sales
Tuesday, December 2, 2014 - 9:31am | 140Read More...Walgreen Company (NYSE: WAG) is scheduled to report its November sales on Wednesday before market open. Ricky Goldwasser of Morgan Stanley is expecting Walgreens to report a total sales comp of 4.2 percent year-over-year, or 5.6 percent adjusted for calendar day shift impact. The analyst's...
-
UPDATE: Morgan Stanley Upgraded McKesson and Introduced PT
Friday, October 25, 2013 - 11:22am | 226Read More...In a report published Friday, Morgan Stanley analyst Ricky Goldwasser upgraded McKesson Corporation (NYSE: MCK) from Equal-weight to Overweight and introduced a PT of $177. Goldwasser reported that McKesson is likely to achieve, and possibly exceed, synergy targets. The analyst commented, “Supply...

